Download Free Sample Report

This report contains market size and forecasts of Transplant Drug Monitoring Assay in Global, including the following market information:

• Global Transplant Drug Monitoring Assay Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global top five companies in 2022 (%)

The global Transplant Drug Monitoring Assay market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Chromatography-MS Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Transplant Drug Monitoring Assay include Abbott, Thermo Fisher Scientific, H.U. Group (Fujirebio), Hoffmann-La Roche, Siemens Healthineers, Hologic, Danaher and Bio-Rad Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transplant Drug Monitoring Assay companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transplant Drug Monitoring Assay Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Transplant Drug Monitoring Assay Market Segment Percentages, by Type, 2022 (%)

• Chromatography-MS
• Immunoassays

Global Transplant Drug Monitoring Assay Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Transplant Drug Monitoring Assay Market Segment Percentages, by Application, 2022 (%)

• Hospital Laboratories
• Commercial & Private Laboratories
• Others

Global Transplant Drug Monitoring Assay Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Transplant Drug Monitoring Assay Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Transplant Drug Monitoring Assay revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Transplant Drug Monitoring Assay revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Thermo Fisher Scientific
• H.U. Group (Fujirebio)
• Hoffmann-La Roche
• Siemens Healthineers
• Hologic
• Danaher
• Bio-Rad Laboratories